Related Experiment Video
Updated: Jul 12, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Pediatric cancers in the new millennium: dramatic progress, new challenges.
Lisa M McGregor1, Monika L Metzger, Robert Sanders
1Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.
Oncology (Williston Park, N.Y.)
|August 29, 2007
Summary
Pediatric cancer survival rates have dramatically increased over 50 years, exceeding 80%. Advances in tumor biology, multidisciplinary care, and clinical research drive progress, but long-term survivor care presents new challenges.
Area of Science:
- Pediatric Oncology
- Cancer Research
- Tumor Biology
Background:
- Childhood cancer survival rates have significantly improved over the past five decades.
- Survival probability increased from less than 25% in the 1960s to over 80% today.
Purpose of the Study:
- To review progress in pediatric oncology over the past three decades.
- To identify new challenges in the field of childhood cancer.
Main Methods:
- Review of advancements in tumor biology.
- Analysis of multidisciplinary care team development.
- Evaluation of incremental therapy improvements.
- Assessment of specialized cancer centers and clinical studies.
- Examination of cooperative group mechanisms for clinical research.
Main Results:
- Significant progress in diagnosis, treatment, and survival of pediatric cancers.
- Most children in developed countries receive adequate care, but access is limited in developing nations.
- A growing population of cancer survivors requires ongoing medical and psychosocial follow-up for late treatment effects.
Conclusions:
- Pediatric oncology has seen remarkable success, transforming survival rates.
- The success of cancer treatment creates a new challenge: managing long-term effects in survivors.
- Future efforts must address both treatment efficacy and comprehensive survivor care, particularly in resource-limited settings.
Related Concept Videos
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...